An apoferritin-based drug delivery system for the tyrosine kinase inhibitor Gefitinib

摘要

Anticancer drug Gefitinib encapsulated within human heavy chain apoferritin by diffusion allows pH-controlled sustained release of cargo. The combination of increased cellular uptake, and potent and enhanced antitumor activity against the HER2 overexpressing SKBR3 cell line compared to Gefitinib alone, makes it a promising carrier for delivery of drugs to tumor sites. © 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.